Zhenggang Ren

机构：Sun Yat-sen University, Fudan University, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University

发表论文 23 篇 · 总被引 105 次 · h-index 6

代表论文

• Elevation of serum γ-glutamyltransferase as a predictor of aggressive tumor behaviors and unfavorable prognosis in patients with intrahepatic cholangiocarcinoma (2013 · European Journal of Gastroenterology & Hepatology · 被引 33)
• Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching (2015 · Journal of Gastroenterology and Hepatology · 被引 19)
• Phase 2 Study of the PD-1 Inhibitor Serplulimab plus the Bevacizumab Biosimilar HLX04 in Patients with Previously Treated Advanced Hepatocellular Carcinoma (2022 · Liver Cancer · 被引 15)
• Prognostic Significance of Hes-1, a Downstream Target of Notch Signaling in Hepatocellular Carcinoma (2015 · Asian Pacific Journal of Cancer Prevention · 被引 10)
• LEAP-002 long-term follow-up: Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma. (2025 · Journal of Clinical Oncology · 被引 7)
• Real-world study of hepatic artery infusion chemotherapy combined with anti-PD-1 immunotherapy for hepatocellular carcinoma patients with portal vein tumor thrombus (2024 · Therapeutic Advances in Medical Oncology · 被引 7)